A new University of Kentucky College of Medicine study provides insight into how a protein called angiotensinogen (AGT) contributes to blood pressure regulation and atherosclerosis.
KYNETIC, funded by the National Institutes of Health (NIH), is excited to announce that five of the seven projects recently awarded $50,000 to bring their innovations toward product development are from the University of Kentucky.
“Both areas will answer important questions about how platelets work, which could directly contribute to drug development for human diseases, especially thrombotic diseases and chronic viremia,” Whiteheart said.
In this edition of People Behind Our Research, UK's Ann Stowe explains her work to understand how inflammation after stroke can be shaped to support rewiring in the brain and recovery of function that might be lost with injury.
In its sixth consecutive year, the Healthy Hearts for Women Symposium features scientists from UK and universities across the country, who present research and new findings in women’s heart health and translational cardiovascular medicine.
New research shows that the microorganisms in our gut could help protect brain cells from damage caused by inflammation after a stroke. The study reveals that supplementing the body’s short chain fatty acids could improve stroke recovery.
A new biomarker, uncovered by researchers in the University of Kentucky College of Pharmacy, could change cardiovascular care for patients with high risk of disease.
The UK Office of Technology Commercialization (OTC) worked with four UK innovators to pitch their technologies at the inaugural Founder Hunt event at Churchill Downs in Louisville.
